Shanghai aims to reopen more COVID-19-shut businesses, while Beijing battles on
All but shut down for more than six weeks, Shanghai is tightening curbs in some areas that it hopes marks a final push in its campaign against the virus.
Japan's parliament OKs bill for emergency approval of drugs and vaccines
The establishment of the new system comes after Japan lagged behind the United States and European countries in approving COVID-19 vaccines.
34 volunteers chose to get COVID-19. Here’s what scientists learned.
One of the first big surprises was how short the COVID incubation period was; it took only two days before the volunteers tested positive on PCR tests and soon after that on the rapid tests.
How often do we have to get COVID to stop getting COVID?
Natural immunity will be key to downshifting the pandemic to endemic status. That doesn’t mean you should go out and try to catch the virus tomorrow.
Japan to limit scope of fourth jabs to older people and those at higher risk
Arrangements for fourth doses, positioned as part of a publicly funded emergency vaccination program, are aimed at preventing people from developing severe COVID-19 symptoms.
Government data shows 86.9% of those age 65 and above have received their third dose, but the rate for younger people is still low relative to the general population.
Japan's Shionogi says COVID-19 pill shows rapid clearance of virus
The pill, S-217622, "demonstrated rapid clearance of the infectious SARS-CoV-2 virus," the Japanese drugmaker Shionogi says.
Leader of QAnon's Japan arm held for obstructing COVID-19 vaccinations
Hiroyuki Kuraoka was arrested on suspicion of forcing his way into a venue offering coronavirus vaccinations for children in Tokyo.
Many in Japanese government seeking to limit rollout of fourth COVID shots
Calls to focus mostly on the elderly and those with underlying conditions reflect findings from foreign countries that show additional inoculation is not highly effective for young people.
Is COVID more dangerous than driving? How scientists are parsing COVID-19 risks.
Even two years into the pandemic, the coronavirus remains new enough, and its long-term effects unpredictable enough, that measuring the threat posed by an infection is a thorny problem.
A health ministry panel of experts said that it is necessary to keep a close watch on the XE subvariant through genome sequencing.
The Finance Ministry has said that the country should consider the cost-effectiveness of vaccinations, as the amount of doses procured exceeds how many are needed for its entire population.
